NCT01810835View on ClinicalTrials.gov

Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination.

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Hepatitis B
Trial Locations (2)

75475

Hopital Lariboisiere, Paris

Unknown

Paris

All Listed Sponsors
lead

Hopital Lariboisière

OTHER

NCT01810835 - Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. | Biotech Hunter | Biotech Hunter